Stefano Cascinu

Marche Polytechnic University

H指数:80

被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life

DIGESTIVE AND LIVER DISEASE

IF3.8

2025-01-010

PRE

Lenvatinib (L) versus sorafenib (S) second-line therapy in hepatocellular carcinoma (HCC) patients (P) progressed to atezolizumab plus bevacizumab (AB)

仑伐替尼（L）与索拉非尼（S）在进展至阿替利珠单抗联合贝伐珠单抗（AB）方案后的肝细胞癌（HCC）患者（P）中的二线治疗

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab

SCIENTIFIC REPORTS

IF3.9

2024-08-301

OAAI

Rimini, Margherita; Montes, Margarida; Amadeo, Elisabeth; Vitiello, Francesco; Kudo, Masatoshi; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Lonardi, Sara; Finkelmeier, Fabian; Salani, Francesca; Antonuzzo, Lorenzo; Marra, Fabio; Iavarone, Massimo; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Sacco, Rodolfo; Rapposelli, Ilario Giovanni; Scartozzi, Mario; Nicoletta, Pella; Aldrighetti, Luca; Persano, Mara; Camera, Silvia; Rossari, Federico; Foti, Silvia; Kumada, Takashi; Hiraoka, Atsushi; Iwamoto, Hideki; Rizzato, Mario Domenico; Himmelsbach, Vera; Masi, Gianluca; Corradi, Mattia; Celsa, Ciro; Fabio, Conti; Frassineti, Giovanni Luca; Cascinu, Stefano; Casadei-Gardini, Andrea; Presa, Jose

International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape (vol 27, 649, 2024)

GASTRIC CANCER

IF5.1

2024-06-170

OAAI

Morgagni, Paolo; Bencivenga, Maria; Carneiro, Fatima; Cascinu, Stefano; Derks, Sarah; Di Bartolomeo, Maria; Donohoe, Claire; Eveno, Clarisse; Gisbertz, Suzanne; Grimminger, Peter; Gockel, Ines; Grabsch, Heike; Kassab, Paulo; Langer, Rupert; Lonardi, Sara; Maltoni, Marco; Markar, Sheraz; Moehler, Markus; Marrelli, Daniele; Mazzei, Maria Antonietta; Melisi, Davide; Milandri, Carlo; Moenig, Paul Stefan; Mostert, Bianca; Mura, Gianni; Polkowski, Wojciech; Reynolds, John; Saragoni, Luca; Henegouwen, Mark I. Van Berge; Van Hillegersberg, Richard; Vieth, Michael; Verlato, Giuseppe; Torroni, Lorena; Wijnhoven, Bas; Tiberio, Guido Alberto Massimo; Yang, Han-Kwang; Roviello, Franco; de Manzoni, Giovanni; Allum, William; Bagnacci, Giulio; Baiocchi, Gian Luca; Berlth, Felix; Borgno, Laura; Yan, Jimmy So Bok; Caccialanza, Riccardo; Casella, Francesco; Castelli, Claudia; Chevallay, Mikael; Corso, Simona; Matos Da Costa, Paulo; Dal Cero, Mariagiulia; De Giuli, Maurizio; De Pascale, Stefano; Donini, Annibale; D'Ugo, Domenico; Ercolani, Giorgio; Filippini, Federica; Framarini, Massimo; Frejlich, Ewelina; Romario, Uberto Fumagalli; Giacopuzzi, Simone; Giordano, Silvia; Graziosi, Luigina; Hartgrink, Henk; Hoelscher, Arnulf H.; Kim, Jeesun; Kroese, Tiuri; Gomes, Lourenco Laercio; Santos, Lucio Lara; Liu, Drolaiz; Lordick, Florian; Marano, Luigi; Marino, Elisabetta; Martinelli, Giovanni; Meyer, Hans-Joachim; Ministrini, Silvia; Mansfield, Paul F.; Molinari, Chiara; Monti, Manlio; Moulla, Yusef; Nilsson, Magnus; Patuzzo, Sara; Pera, Manuel; Prado Castro, Osvaldo Antonio; Quinzii, Alberto; Rapposelli, Ilario Giovanni; Rausei, Stefano; Reddavid, Rossella; Rosa, Fausto; Rosati, Riccardo; Rossi, Romina; Roviello, Giandomenico; Rudno-Rudzinska, Julia; Sacco, Michele; Salati, Massimiliano; Schneider, Paul M.; Solaini, Leonardo; Terashima, Masanori; Tomezzoli, Anna; Valgiusti, Martina; Weston, Antonio Carlos; Wojciech, Kielan; Thortsen, Goetze

Lenvatinib (L) versus sorafenib (S) second-line therapy in hepatocellular carcinoma (HCC) patients (P) progressed to atezolizumab plus bevacizumab (AB)

ANNALS OF ONCOLOGY

IF65.4

2024-06-010

PRE

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

TARGETED ONCOLOGY

IF4

2024-05-019

PRE

Rimini, Margherita; Masi, Gianluca; Lonardi, Sara; Pressiani, Tiziana; Lavacchi, Daniele; Nichetti, Federico; Jessica, Lucchetti; Giordano, Guido; Scartozzi, Mario; Tamburini, Emiliano; Pastorino, Alessandro; Rapposelli, Ilario Giovanni; Daniele, Bruno; Martinelli, Erika; Garajova, Ingrid; Aprile, Giuseppe; Schirripa, Marta; Formica, Vincenzo; Salani, Francesca; Winchler, Costanza; Bergamo, Francesca; Balsano, Rita; Gusmaroli, Eleonora; Lorenzo, Angotti; Landriscina, Matteo; Pretta, Andrea; Toma, Ilaria; Pirrone, Chiara; Diana, Anna; Leone, Francesco; Brunetti, Oronzo; Brandi, Giovanni; Garattini, Silvio Ken; Satolli, Maria Antonietta; Rossari, Federico; Fornaro, Lorenzo; Niger, Monica; Zanuso, Valentina; De Rosa, Antonio; Ratti, Francesca; Aldrighetti, Luca; De Braud, Filippo; Foti, Silvia; Rizzato, Mario Domenico; Vivaldi, Caterina; Stefano, Cascinu; Rimassa, Lorenza; Antonuzzo, Lorenzo; Casadei-Gardini, Andrea

Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab

不良事件是晚期HCC患者接受阿特珠单抗联合贝伐单抗治疗的潜在预测因素

TARGETED ONCOLOGY

IF4

2024-04-301

OAAI

Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Rossari, Federico; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo Alberto; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Solda, Caterina; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Bruccoleri, Mariangela; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Foti, Silvia; Camera, Silvia; Piscaglia, Fabio; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea

International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape Bertinoro Workshop, November 2022

GASTRIC CANCER

IF5.1

2024-04-184

OAAI

Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study

LIVER CANCER

IF9.1

2024-04-106

OAAI

Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Solda, Caterina; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Foti, Silvia; Camera, Silvia; Stefanini, Bernardo; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea; Rimini, Margherita

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

体重指数对接受一线乐伐替尼或阿特珠单抗联合贝伐单抗治疗的不可切除HCC患者预后的影响

LIVER INTERNATIONAL

IF5.2

2024-03-222

PRE

Rimini, Margherita; Stefanini, Bernardo; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Finkelmeier, Fabian; Yoo, Changhoon; Presa, Jose; Amadeo, Elisabeth; Genovesi, Virginia; De Grandis, Maria Caterina; Iavarone, Massimo; Marra, Fabio; Foschi, Francesco; Tamburini, Emiliano; Rossari, Federico; Vitiello, Francesco; Bartalini, Linda; Solda, Caterina; Tovoli, Francesco; Vivaldi, Caterina; Lonardi, Sara; Silletta, Marianna; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Himmelsbach, Vera; Montes, Margarida; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Camera, Silvia; Foti, Silvia; Aldrighetti, Luca; Cascinu, Stefano; Casadei-Gardini, Andrea; Piscaglia, Fabio

Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma

DIGESTIVE AND LIVER DISEASE

IF3.8

2024-03-012

PRE

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma

Lenvatinib在高龄不可切除的肝细胞癌患者中的安全性和有效性

TARGETED ONCOLOGY

IF4

2024-01-222

PRE

Camera, Silvia; Rimini, Margherita; Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Salani, Francesca; Marseglia, Mariarosaria; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Lonardi, Sara; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Foti, Silvia; Piscaglia, Fabio; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea

α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Α-fate: 阿特珠单抗联合贝伐单抗治疗不可切除肝细胞癌的新预测评分

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-11-238

PRE

Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Solda, Caterina; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Burgio, Valentina; Piscaglia, Fabio; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea; Rimini, Margherita

Lenvatinib (L) versus sorafenib (S) second-line therapy in hepatocellular carcinoma (HCC) patients progressed to atezolizumab plus bevacizumab (AB)

ANNALS OF ONCOLOGY

IF65.4

2023-11-010

PRE

The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study

ANNALS OF ONCOLOGY

IF65.4

2023-11-010

PRE

Determinants of Therapeutic Sensitivity in EGFR-Driven Lung Cancer

EUROPEAN RESPIRATORY JOURNAL